首页> 外文OA文献 >Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
【2h】

Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.

机译:CHO细胞上5-HT1B受体的特征:在没有放射性配体结合的情况下的功能性反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Chinese hamster ovary (CHO) cells have been reported to be devoid of 5-HT receptors and have frequently been used as hosts for the expression of cloned 5-HT receptors. Unexpectedly, 5-HT was found to induce profound inhibition of forskolin-stimulated cyclic AMP production in these cells and the aim of this study was to classify the 5-HT receptor involved. 2. In CHO(dhfr-) cells 5-HT was a potent agonist and caused 80-100% inhibition of forskolin stimulated cyclic AMP production. A study using several 5-HT1 receptor agonists revealed the following potencies (p[A50]): RU24969 (9.09 +/- 0.17) > 5-carboxamidotryptamine (8.86 +/- 0.20) > 5-HT (8.07 +/- 0.05) > CP-93,129 (7.74 +/- 0.10) > sumatriptan (5.93 +/- 0.04). All five agonists achieved a similar maximum effect. Irreversible receptor alkylation studies yielded a pKA estimate of 7.04 +/- 0.34 for 5-HT. 3. The 5-HT1A/1B antagonist, (+/-)-cyanopindolol (4-100 nM), caused parallel rightward shifts of the 5-HT concentration-effect curve with no change in asymptote. Schild analysis yielded a pKB estimate of 8.69 +/- 0.09 (Schild slope 1.13 +/- 0.10). (+/-)-Cyanopindolol actually behaved as a partial agonist with an intrinsic activity of 0.2-0.5 and a p[A50] of 8.55. 4. 5-HT (0.01-10 microM) also elicited a concentration-dependent increase in intracellular [Ca2+] in CHO(dhfr-) cells thus demonstrating that dual coupling is not a phenomenon restricted to systems in which there is overexpression of transfected receptors. 5. This agonist and antagonist profile is consistent with the presence of a 5-HT1B receptor. 8-OH-DPAT (1 microM) and renzapride (3 microM) were without effect on forskolin-stimulated cyclic AMP production and ketanserin (0.3 microM) did not antagonize the inhibition produced by 5-HT, thus excluding the involvement of 5-HT1A, 5-HT4, and 5-HT2 receptors. 6. The possibility that expression of a 5-HT1B receptor was associated with the dhfr- mutation was excluded since RU24969, 5-HT and CP-93,129 were also potent agonists in unmutated, CHO-K1 cells: p[A50] 9.03 +/- 0.03, 8.34 +/- 0.05, 7.69 +/- 0.07 respectively, and (+/-)-cyanopindolol (0.1 microM) shifted the 5-HT curve to the right and yielded a pA2 estimate of 8.70 +/- 0.06. 7. Little or no specific binding of [3H]-5-HT (0.1-200 nM) or of the high affinity ligand [125I]-iodocyanopindolol (0.01-3 nM) to CHO(dhfr-) cell membranes could be detected. 5-HT also failed to elicit any increase in the binding of [35S]-GTP gamma S to CHO membranes. 8. In conclusion, cultured CHO cells express 5-HT1B receptors which are negatively coupled to adenylyl cyclase and positively coupled to increases in intracellular calcium. The absence of radioligand binding was unexpected in view of the high potency of 5-HT and the partial agonist activity of the normally 'silent' competitive antagonist, (+/-)-cyanopindolol. This implies very efficient receptor-effector coupling of a low density of 5-HT1B receptors. Clearly, the absence of detectable radioligand binding cannot be assumed to mean the absence of receptors capable of eliciting a significant functional response.
机译:1.据报道,中国仓鼠卵巢(CHO)细胞不含5-HT受体,并且经常用作表达克隆的5-HT受体的宿主。出乎意料的是,发现5-HT在这些细胞中诱导了福斯科林刺激的环AMP产生的显着抑制作用,并且本研究的目的是对涉及的5-HT受体进行分类。 2.在CHO(dhfr-)细胞中,5-HT是一种强效激动剂,可抑制毛喉素刺激的环AMP产生80-100%。使用几种5-HT1受体激动剂的研究显示出以下功效(p [A50]):RU24969(9.09 +/- 0.17)> 5-羧酰胺基色胺(8.86 +/- 0.20)> 5-HT(8.07 +/- 0.05) > CP-93,129(7.74 +/- 0.10)>舒马普坦(5.93 +/- 0.04)。所有五种激动剂均达到了相似的最大效果。不可逆受体烷基化研究得出5-HT的pKA估计值为7.04 +/- 0.34。 3. 5-HT1A / 1B拮抗剂(+/-)-氰基吲哚洛尔(4-100 nM)导致5-HT浓度-效应曲线平行向右移动,渐近线没有变化。 Schild分析得出的pKB估计值为8.69 +/- 0.09(Schild斜率1.13 +/- 0.10)。 (+/-)-氰基吲哚洛尔实际上是部分激动剂,其固有活性为0.2-0.5,p [A50]为8.55。 4. 5-HT(0.01-10 microM)还引起CHO(dhfr-)细胞内细胞内[Ca2 +]浓度依赖性增加,因此表明双重偶联并非仅限于其中转染受体过表达的系统。 。 5.该激动剂和拮抗剂的特征与5-HT1B受体的存在是一致的。 8-OH-DPAT(1 microM)和伦扎必利(3 microM)对毛喉素刺激的环AMP产生没有影响,而酮色林(0.3 microM)不能拮抗5-HT产生的抑制作用,因此排除了5-HT1A的参与,5-HT4和5-HT2受体。 6.排除了5-HT1B受体表达与dhfr-突变相关的可能性,因为RU24969、5-HT和CP-93,129也是未突变的CHO-K1细胞中的有效激动剂:p [A50] 9.03 + / -分别为0.03、8.34 +/- 0.05、7.69 +/- 0.07,并且(+/-)-氰基吲哚醇(0.1 microM)将5-HT曲线向右移动,得出pA2估计值为8.70 +/- 0.06。 7.几乎没有检测到[3H] -5-HT(0.1-200 nM)或高亲和力配体[125I]-碘氰基吲哚洛尔(0.01-3 nM)与CHO(dhfr-)细胞膜的特异性结合。 5-HT也未能引起[35S] -GTPγS与CHO膜结合的任何增加。 8.总之,培养的CHO细胞表达5-HT1B受体,这些受体与腺苷酸环化酶负相关,而与细胞内钙的增加正相关。鉴于5-HT的高效力和通常“沉默”的竞争性拮抗剂(+/-)-氰基吲哚醇的部分激动剂活性,因此没有放射性配体结合是出乎意料的。这意味着低密度的5-HT1B受体非常有效的受体-效应子偶联。显然,不存在可检测的放射性配体结合不能被认为是意味着不存在能够引起明显功能反应的受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号